Celebrating 15 years of the Injectable Device Development Summit
Enable Advanced Delivery of Complex Biologics, Optimize Patient-Centric Device Design & Accelerate Combination Product Development
Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2026 event, please get in touch at info@hansonwade.com
The drug delivery landscape is evolving rapidly, with micro moulding driving evolving trends in self-injection devices and increasing drive towards sustainability. At the same time, sweeping regulatory shifts are reshaping the future of combination product development, as U.S. policy accelerates domestic drug approvals and heightens oversight of global manufacturing practices.
Built for device innovators by industry pioneers, the 15th Injectable Device Development Summit united 60+ senior leaders from pharma, biotech, and device service providers including Eli Lilly, Takeda, Sanofi, and Merck, to unpack how to enable flexible, patient-centric delivery platforms for high-viscosity, large-volume formulations. From advancing platform strategies to de-risking regulatory pathways and improving real-world usability, this was the essential forum to drive forward next-generation delivery systems that meet the needs of both regulators and patients.
This event was FREE* to attend for drug developers to support delivery innovation and product development while connecting delegates with expert partners to find the right device solutions.
What was New for 2025?
- Overcome delivery challenges of large-volume biologics by aligning formulation, device innovation, and risk strategies to ensure safe, patient-friendly solution.
- Accelerate device submissions by leveraging platform strategies, optimizing resources, and balancing portfolio priorities for faster, scalable development.
- Improve product safety by embedding patient-centric design into risk management and device selection, ensuring delivery solutions meet real-world user needs.
- Streamline injectable device supply chains by selecting fully integrated partners that reduce risk, minimize delays, and support scalable, end-to-end development.
Your 2025 Speaker Faculty Included:
Who Attended?:
See Why Attendees Joined Them:
2025 Partners:
